These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1557756)

  • 1. [Li-Fraumeni syndrome and the p53 gene].
    Thoresen SO
    Tidsskr Nor Laegeforen; 1992 Mar; 112(7):887-9. PubMed ID: 1557756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Li-Fraumeni syndrome].
    Frebourg T
    Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up study of twenty-four families with Li-Fraumeni syndrome.
    Garber JE; Goldstein AM; Kantor AF; Dreyfus MG; Fraumeni JF; Li FP
    Cancer Res; 1991 Nov; 51(22):6094-7. PubMed ID: 1933872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.
    Birch JM; Hartley AL; Tricker KJ; Prosser J; Condie A; Kelsey AM; Harris M; Jones PH; Binchy A; Crowther D
    Cancer Res; 1994 Mar; 54(5):1298-304. PubMed ID: 8118819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Li-Fraumeni syndrome and germ-line mutations of the p53 gene].
    Leblanc T; Soussi T
    Arch Pediatr; 1994 Jan; 1(1):61-70. PubMed ID: 8087224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Germline mutations of the p53 gene].
    Frebourg T
    Pathol Biol (Paris); 1997 Dec; 45(10):845-51. PubMed ID: 9769948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Li-Fraumeni syndrome].
    Tokunaga A; Onda M; Matsukura N; Kato S
    Nihon Rinsho; 1995 Nov; 53(11):2797-802. PubMed ID: 8538047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germ-line splicing mutation of the p53 gene in a cancer-prone family.
    Warneford SG; Witton LJ; Townsend ML; Rowe PB; Reddel RR; Dalla-Pozza L; Symonds G
    Cell Growth Differ; 1992 Nov; 3(11):839-46. PubMed ID: 1467311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer risks from germ line tumor suppressor gene mutations.
    Frebourg T; Malkin D; Friend S
    Princess Takamatsu Symp; 1991; 22():61-70. PubMed ID: 1844252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
    Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA
    Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline mutations of the p53 tumor-suppressor gene in cancer-prone families: a review.
    Soussi T; Leblanc T; Baruchel A; Schaison G
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):33-6. PubMed ID: 8511038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
    Gonzalez KD; Noltner KA; Buzin CH; Gu D; Wen-Fong CY; Nguyen VQ; Han JH; Lowstuter K; Longmate J; Sommer SS; Weitzel JN
    J Clin Oncol; 2009 Mar; 27(8):1250-6. PubMed ID: 19204208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies.
    Pötzsch C; Voigtländer T; Lübbert M
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):456-60. PubMed ID: 12200603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [When is it useful to look for TP53 germline gene mutations in families of oncology patients?].
    Trková M; Sedlácek Z
    Cas Lek Cesk; 2003; 142(4):220-5. PubMed ID: 12841124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balanced t(11;15)(q23;q15) in a TP53+/+ breast cancer patient from a Li-Fraumeni syndrome family.
    Sherif ZA; Danielsen M
    Cancer Genet Cytogenet; 2006 Jul; 168(1):50-8. PubMed ID: 16772121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial aggregation of soft tissue sarcomas: a report of three cases from a Li-Fraumeni-like family.
    Narita T; Dobashi Y; Nakamura T; Yokoyama S; Matsuda K
    Arch Pathol Lab Med; 1997 May; 121(5):493-8. PubMed ID: 9167603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome.
    Quesnel S; Verselis S; Portwine C; Garber J; White M; Feunteun J; Malkin D; Li FP
    Oncogene; 1999 Jul; 18(27):3970-8. PubMed ID: 10435620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetics and cancer of the breast].
    Sobol H; Bignon YJ; Eisinger F; Birnbaum D; Fervers B
    Ann Chir; 1994; 48(4):303-8. PubMed ID: 8085754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Li-Fraumeni syndrome: update, new data and guidelines for clinical management].
    Frebourg T; Abel A; Bonaiti-Pellie C; Brugières L; Berthet P; Bressac-de Paillerets B; Chevrier A; Chompret A; Cohen-Haguenauer O; Delattre O; Feingold J; Feunteun J; Frappaz D; Fricker JP; Gesta P; Jonveaux P; Kalifa C; Lasset C; Leheup B; Limacher JM; Longy M; Nogues C; Oppenheim D; Sommelet D; Soubrier F; Stoll C; Stoppa-Lyonnet D; Tristant H
    Bull Cancer; 2001 Jun; 88(6):581-7. PubMed ID: 11459705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.
    Birch JM; Blair V; Kelsey AM; Evans DG; Harris M; Tricker KJ; Varley JM
    Oncogene; 1998 Sep; 17(9):1061-8. PubMed ID: 9764816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.